AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 66 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $508,000 | +379.2% | 812,994 | +548.6% | 0.06% | +321.4% |
| Q3 2019 | $106,000 | -25.4% | 125,346 | -40.4% | 0.01% | -12.5% |
| Q2 2019 | $142,000 | -74.9% | 210,474 | -69.4% | 0.02% | -71.9% |
| Q1 2019 | $565,000 | +946.3% | 688,431 | +4583.2% | 0.06% | +1325.0% |
| Q3 2017 | $54,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |